UTHealth Houston Research

October 7, 2024

First infusion in Houston for new Alzheimer’s drug administered at UTHealth Houston

Written By: Jeannette Sanchez | Updated: October 7, 2024

UTHealth Houston is the first institution in Houston to administer an FDA-approved drug, Kisunla (donanemab-azbt), for the treatment of early symptomatic Alzheimer’s disease. The recipient, 79-year-old Terrie Frankel, received the infusion last week.

September 26, 2024

At the Bedside: Houston attorney shares her story of living with sickle cell anemia

Written By: Office of Public Affairs | Updated: September 26, 2024

From the outside, there is nothing about successful, busy attorney Brenda Adimora that hints at a disease she has fought all of her life. She maintains an active practice as a labor and employment attorney and was chair of the board of trustees of the Houston Young Lawyers Foundation.

September 26, 2024

At The Bedside: For Jesus Mata, living with idiopathic pulmonary fibrosis is not the end, but the beginning

Written By: Sydney Lowther | Updated: September 26, 2024

Since he could remember, Jesus Mata has always had a cough he could not seem to kick. He had no idea that his simple cough was a sign of a serious and life-altering illness.

September 25, 2024

UTHealth Houston’s minimally invasive treatment extends hope to patients with medication-resistant epilepsy

Written By: Laura Frnka-Davis | Updated: September 25, 2024

Findings of a study on a novel and minimally invasive laser therapy for patients with drug-resistant epilepsy caused by periventricular nodular heterotopia (PNVH) have been published by UTHealth Houston researchers in American Neurological Association’s Annals of Neurology.

September 19, 2024

Grants for $3.5M from TARCC fund new Alzheimer’s disease research at UTHealth Houston

Written By: Deborah Mann Lake | Updated: September 19, 2024

Studies by researchers at UTHealth Houston seeking to understand the underlying pathology of Alzheimer’s disease in order to discover new pathways to treatment have earned multiple awards totaling $3.5 million from the Texas Alzheimer’s Research and Care Consortium (TARCC).

September 19, 2024

First patient in Texas, Southeast US, enrolled at UTHealth Houston for study of neural cell therapy product to treat epilepsy

Written By: Deborah Mann Lake | Updated: September 19, 2024

UTHealth Houston has enrolled the first patient in the Southeastern United States into a national Phase I/II clinical trial testing whether a neural cell therapy product can help inhibit the abnormal electrical activity that leads to an epileptic seizure.

September 19, 2024

The Ocean Corporation collaborates with UTHealth Houston on Space Medicine Fellowship program

Written By: Office of Public Affairs | Updated: September 19, 2024

UTHealth Houston and The Ocean Corporation are collaborating on UTHealth Houston’s Space Medicine Training Fellowship program, which now includes a two-week intensive training focused on hyperbaric technologies and analog environments akin to those astronauts experience during extravehicular activities (EVAs), or space walks.

September 3, 2024

Rare genetic variants linked to bicuspid aortic valve disease in young adults identified by UTHealth Houston researchers

Written By: Sydney Lowther | Updated: September 3, 2024

Genetic variants linked to a rare form of bicuspid aortic valve disease that affects young adults and can lead to dangerous and potentially life-threatening aortic complications have been identified by researchers at UTHealth Houston.

August 30, 2024

UTHealth Houston and Baylor College of Medicine collaborate on first CDC Injury Control Research Center in Southwest, established to study injury and violence prevention

Written By: Revathi Janaswamy | Updated: August 30, 2024

The only Injury Control Research Center in Texas has been established by the Centers for Disease Control and Prevention at UTHealth Houston in partnership with Baylor College of Medicine.

August 19, 2024